Drug Approval | August 19, 2024
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
The approved product has an estimated market size of US$ 268 million for the twelve months ending June 2024, according to IQVIA
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
Reconfirms a relative bioavailability of 65 percent and significant savings when using DL-methionine
A five-day inspection was concluded successfully with no critical and no major observations raised
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Subscribe To Our Newsletter & Stay Updated
